整形外科骨水泥市場－全球產業規模、佔有率、趨勢、機會、預測：按材料、產品類型、最終用戶、地區和競爭對手分類，2021-2031年

全球整形外科骨水泥市場預計將從 2025 年的 8.1911 億美元成長到 2031 年的 11.7249 億美元，複合年成長率為 6.16%。

該市場主要涉及用於關節重建手術中人工關節移植物固定的聚甲基丙烯酸甲酯 (PMMA)填充材。主要成長要素包括老年人口的成長和骨關節炎盛行率的上升，這兩者都需要增加關節重建手術的數量。美國關節關節重建註冊中心報告稱，到 2025 年，手術總量將增加 8.8%，這印證了這一不斷成長的需求。此外，創傷和運動傷害的高發生率也持續推動醫療保健系統對有效固定解決方案的需求。然而，一個主要挑戰是，人們越來越傾向於使用依靠生物固定而非水泥漿的無骨植入，尤其是在年輕患者和北美市場。這直接減少了初次手術中骨水泥的使用，加劇了製造商之間的競爭壓力。

市場促進因素

骨關節炎和骨質疏鬆症盛行率的上升是市場趨勢的主要促進因素，顯著增加了需要骨水泥固定的患者數量。隨著骨骼密度的下降，外科醫生越來越依賴聚甲基丙烯酸甲酯（PMMA）骨水泥進行即時穩定的植入，尤其是在老年患者中，因為生物相容性和無骨水泥固定往往更加困難。骨脆性帶來的沉重負擔，導致頻繁的手術干預，進一步加劇了這種依賴性。根據國際骨質疏鬆基金會的報告，截至2024年10月，全球55歲及以上人群每年將發生多達3700萬例脆性骨折，凸顯了在骨折治療和重組手術中可靠固定的迫切需求。因此，醫療保健系統必須保持充足的骨水泥庫存。同時，關節重建和關節成形術的激增也直接推動了產品的消費。這主要歸因於手術適應症的擴大，涵蓋了更多年輕、活躍的患者，以及手術等待名單的取消，從而導致使用骨水泥固定的膝關節和髖關節手術頻率增加。手術數量的成長反映了強勁的市場需求。預計到2024年10月，史賽克（Stryker）美國膝關節業務的內部成長將達到8.4%，而史密斯-內普（Smith & Nephew）整形外科部門的核心銷售額到2025年2月將成長6.0%。這凸顯了關節重組市場的持續商業性擴張以及由此產生的對骨水泥的需求。

市場挑戰

市場成長的主要限制因素是無骨植入的加速普及，這種植入物採用生物固定而非基於聚甲基丙烯酸甲酯（PMMA）的骨水泥。這一趨勢從根本上限制了市場，因為越來越多的關節重建手術不再需要骨水泥。隨著外科醫生越來越傾向於使用能夠促進自然骨嵌入的壓入植入，尤其是在骨質良好的年輕患者中，骨水泥產品的潛在市場規模正在顯著縮小。這一趨勢實際上繞過了初次手術中的骨水泥市場，迫使製造商更加依賴重新置換市場和老年患者。近期行業數據也印證了這一市場佔有率的萎縮趨勢。根據美國關節置換註冊中心（American Joint 關節重建 Registry）2024年的年度報告，2023年，初次全膝關節置換術中採用無骨水泥固定的比例約佔所有手術的22%，並呈現逐年上升的趨勢。在膝關節固定領域，骨水泥固定一直是傳統上的主要方法，但生物假體固定方法的穩定成長表明骨水泥的使用正在被直接取代，這限制了收入潛力，並為傳統的骨水泥供應商造成了長期的結構性障礙。

市場趨勢

隨著醫療專業人員將減少假體周圍感染疾病（PJI）列為優先事項，抗菌骨水泥在預防感染方面的應用日益廣泛，這已成為一大趨勢。外科醫生正在廣泛推廣在初次手術和重新置換手術中使用抗菌浸漬的固定材料，以降低化膿性感染失敗的巨大經濟和臨床成本。這種預防策略已在全球主要市場的臨床實踐中站穩腳跟，其主要驅動力在於防止術後植入立即發生細菌定植。發表於2024年5月《美國醫學會雜誌網路公開版》（JAMA Network Open）的一項研究分析了國際註冊數據，結果顯示，在調查的210萬例初次膝關節關節重建中，93%使用了抗菌骨水泥。同時，對於現代微創手術（MIS）技術而言，具有優異操作性能的高黏度骨水泥的需求也在不斷成長。這些配方能夠實現即時穩定性和可控應用，從而在有限的手術視野內實現更精確的壓力施加，同時降低骨水泥滲漏到周圍組織的風險。為此，製造商正在開發含有兩種抗生素的先進高黏度產品，以應對複雜的抗藥性問題，同時又不影響機械強度。例如，賀利氏醫療（Heraeus Medical）於2024年8月推出的骨水泥「COPAL G+V」。本產品採用高黏度配方，含有慶大霉素和萬古黴素，以確保穩定的固定效果和感染控制。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球整形外科骨水泥市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依材料分類（聚甲基丙烯酸甲酯（PMMA）、陶瓷、丙烯酸酯、其他）
  • 產品類型（低黏度水泥、中黏度水泥、高黏度水泥、含抗生素水泥）
  • 依最終使用者（醫院、整形外科診所/中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美整形外科骨水泥市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲整形外科骨水泥市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區整形外科骨水泥市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲整形外科骨水泥市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲整形外科骨水泥市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球整形外科骨水泥市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Stryker Corporation
• Smith & Nephew PLC
• Johnson & Johnson Services, Inc.
• Zimmer Biomet Holdings, Inc.
• Subiton LABORATORIOS SL SA
• DJO Global Inc.
• Arthrex Inc.
• Tecres SpA
• Synimed SARL

第16章 策略建議

第17章：關於研究公司及免責聲明

The global orthopedic bone cement market is projected to grow from USD 819.11 million in 2025 to USD 1172.49 million by 2031, at a 6.16% compound annual growth rate. This market primarily involves polymethyl methacrylate (PMMA) grouting material used to secure prosthetic implants during joint replacement surgeries. Key growth drivers include an expanding geriatric population and the increasing prevalence of osteoarthritis, both necessitating more arthroplasty procedures. In 2025, the American Joint Replacement Registry reported an 8.8% increase in total procedural volume year-over-year, confirming rising demand. Additionally, high rates of trauma and sports injuries consistently drive the need for effective fixation solutions within healthcare systems. A significant challenge, however, is the growing preference for cementless implants, which rely on biological fixation instead of grouting agents, especially among younger patients and in North American markets, directly reducing bone cement utilization in primary procedures and intensifying competitive pressure on manufacturers.

Market Driver

The rising prevalence of osteoarthritis and osteoporosis is a primary determinant of the market's trajectory, significantly increasing the patient pool requiring cemented fixation. As bone density declines, surgeons increasingly depend on polymethyl methacrylate (PMMA) cement for immediate and stable implant anchorage, particularly in elderly individuals where biological or cementless integration is often compromised. This reliance is amplified by the substantial burden of skeletal fragility, necessitating frequent surgical interventions; the International Osteoporosis Foundation reported up to 37 million fragility fractures annually worldwide in individuals aged over 55 by October 2024, emphasizing the critical need for reliable fixation in fracture management and reconstructive procedures. Consequently, healthcare systems must maintain substantial inventories of bone cement. Concurrently, a surge in joint replacement and arthroplasty surgeries directly boosts product consumption, driven by expanding surgical eligibility to include younger, active patients and the clearing of procedural backlogs, which has intensified the frequency of cemented knee and hip interventions. This operational momentum is reflected in robust demand, such as Stryker's U.S. knee business growing 8.4% organically by October 2024 and Smith+Nephew's Orthopaedics unit achieving 6.0% underlying revenue growth by February 2025, confirming the sustained commercial expansion of the joint reconstruction market and associated demand for cementing agents.

Market Challenge

The primary impediment to market growth is the accelerating shift towards cementless implants, which utilize biological fixation rather than PMMA grouting agents. This trend fundamentally constrains the market by eliminating the necessity for bone cement in a growing proportion of joint replacement procedures. As surgeons increasingly favor press-fit implants that promote natural bone ingrowth-particularly for younger patients with superior bone quality-the total addressable volume for cementing products is significantly diminished. This preference effectively bypasses the bone cement market for primary interventions, compelling manufacturers to depend more heavily on the revision market or older demographic segments. This erosion of market share is substantiated by recent industry data; the American Joint Replacement Registry's 2024 Annual Report indicated that cementless fixation in primary total knee arthroplasties constituted approximately 22% of all procedures recorded in 2023, reflecting a continuous year-over-year increase. The steady rise of biological fixation in the knee segment, traditionally a stronghold for cemented solutions, demonstrates a direct displacement of bone cement usage, thereby limiting revenue potential and creating a long-term structural barrier for traditional bone cement suppliers.

Market Trends

The increasing adoption of antibiotic-loaded bone cements for infection prophylaxis represents a dominant trend, driven by healthcare providers' priority to reduce periprosthetic joint infections (PJI). Surgeons are widely standardizing the use of antimicrobial-impregnated fixatives in primary and revision arthroplasty to mitigate the substantial economic and clinical costs associated with septic failures. This prophylactic strategy is firmly established in clinical practice across major global markets, motivated by the need to protect implants from bacterial colonization immediately post-implantation. According to a May 2024 study in JAMA Network Open, an analysis of international registry data revealed that 93% of the 2.1 million primary total knee arthroplasties reviewed were performed utilizing antibiotic-loaded bone cement. Concurrently, there is a rising preference for high-viscosity cements, which offer superior handling characteristics essential for modern minimally invasive surgery (MIS) techniques. These formulations provide immediate stability and controlled application, reducing the risk of cement leakage into surrounding tissues while enabling more precise pressurization in restricted surgical fields. Manufacturers are responding by developing advanced high-viscosity products that also incorporate dual-antibiotic agents to address complex resistance profiles without compromising mechanical integrity, exemplified by Heraeus Medical's August 2024 launch of COPAL G+V bone cement, featuring a high-viscosity formulation with gentamicin and vancomycin for stable fixation and infection management.

Key Market Players

• Stryker Corporation
• Smith & Nephew PLC
• Johnson & Johnson Services, Inc.
• Zimmer Biomet Holdings, Inc.
• Subiton LABORATORIOS SL S.A
• DJO Global Inc.
• Arthrex Inc.
• Tecres SpA
• Synimed SARL

Report Scope

In this report, the Global Orthopedic Bone Cement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Orthopedic Bone Cement Market, By Material

• Polymethyl Methacrylate (PMMA)
• Ceramic
• Acrylic
• Others

Orthopedic Bone Cement Market, By Product Type

• Low Viscosity Cements
• Medium Viscosity Cements
• High Viscosity Cements
• Antibiotic Cements

Orthopedic Bone Cement Market, By End-User

• Hospitals
• Orthopedic Clinics and Centers
• Others

Orthopedic Bone Cement Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Orthopedic Bone Cement Market.

Available Customizations:

Global Orthopedic Bone Cement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Orthopedic Bone Cement Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material (Polymethyl Methacrylate (PMMA), Ceramic, Acrylic, Others)
  • 5.2.2. By Product Type (Low Viscosity Cements, Medium Viscosity Cements, High Viscosity Cements, Antibiotic Cements)
  • 5.2.3. By End-User (Hospitals, Orthopedic Clinics and Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Orthopedic Bone Cement Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Product Type
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Orthopedic Bone Cement Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Orthopedic Bone Cement Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Orthopedic Bone Cement Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By End-User

7. Europe Orthopedic Bone Cement Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Product Type
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Orthopedic Bone Cement Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Orthopedic Bone Cement Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Orthopedic Bone Cement Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Orthopedic Bone Cement Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Orthopedic Bone Cement Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By End-User

8. Asia Pacific Orthopedic Bone Cement Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Product Type
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Orthopedic Bone Cement Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Orthopedic Bone Cement Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Orthopedic Bone Cement Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Orthopedic Bone Cement Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Material
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Orthopedic Bone Cement Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Material
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Orthopedic Bone Cement Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Product Type
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Orthopedic Bone Cement Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Orthopedic Bone Cement Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Orthopedic Bone Cement Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By End-User

10. South America Orthopedic Bone Cement Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Product Type
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Orthopedic Bone Cement Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Orthopedic Bone Cement Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Orthopedic Bone Cement Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Orthopedic Bone Cement Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Stryker Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Smith & Nephew PLC
• 15.3. Johnson & Johnson Services, Inc.
• 15.4. Zimmer Biomet Holdings, Inc.
• 15.5. Subiton LABORATORIOS SL S.A
• 15.6. DJO Global Inc.
• 15.7. Arthrex Inc.
• 15.8. Tecres SpA
• 15.9. Synimed SARL

16. Strategic Recommendations

17. About Us & Disclaimer